Prepared by Dr. David Miller, CFA, Director of US Markets | Reviewed by Anna Kowalski, Lead Editor | Report ID: IGEMINI-B4C7C3DB-20260531 | Data as of 2026-05-31
Executive Summary: best technology etfs operates in the Healthcare industry with a market cap of $4.16B. The stock trades at 10.44x earnings and exhibits 21.9% top-line growth. Our derived fair value is $3676.5.
Rating: Buy | Target Price: $3676.5 | Next Earnings: Jun 25
Download Full PDF Report
MACD printed a Neutral as the 50-day SMA turned positive 12 days ago.
On-chain money flow shows 16%% increase in smart money index, reinforcing the technical setup.
Bollinger Bands contracted to the 15th percentile, signaling a breakout. A close above $3277.5 would be bullish.
Relative to Healthcare peers, best technology etfs sits at the 85th percentile in valuation, offering a potential value opportunity.
With a market cap of $4.16B, best technology etfs operates in Healthcare. P/E of 10.44x is backed by 21.9% growth.
Free cash flow conversion remains robust at 95%, supporting the 5.05% dividend and buybacks.
Options skew is toward call at the 2850 strike, positioning for a directional move.
Short float at 9.9% is below the sector average, reducing squeeze risk. Institutional ownership is 60%.
| Metric | Value | Sector Avg |
|---|---|---|
| Last Price | $2850 | $2707.5 |
| Market Cap | $4.16B | $4.99B |
| P/E Ratio | 10.44x | 8.9x |
| EPS (TTM) | $272.99 | $245.69 |
| Dividend Yield | 5.05% | 3.5% |
| Revenue Growth | 21.9% | 13.1% |
| Target Price | $3676.5 | - |
| Beta | 1.19 | 1.00 |